Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q16839058> ?p ?o }
Showing triples 1 to 42 of
42
with 100 triples per page.
- Q16839058 subject Q6996296.
- Q16839058 subject Q6998984.
- Q16839058 subject Q8760074.
- Q16839058 abstract "Franklin v. Parke-Davis is a lawsuit filed in 1996 against Parke-Davis, a division of Warner-Lambert Company, and eventually against Pfizer (which bought Warner-Lambert in 2000) under the qui tam provisions of the False Claims Act. The suit was commenced by Dr. David Franklin, a microbiologist hired in the spring of 1996 in a sales capacity at Parke-Davis, a pharmaceutical subsidiary of Warner-Lambert (Warner-Lambert was subsequently acquired by Pfizer in 2000). In denying the defendants' motion for summary judgment, the court for the first time recognized off-label promotion of drugs could cause Medicaid to pay for prescriptions that were not reimbursable, triggering False Claims Act liability. The case was also significant in exposing the degree to which publication bias impacts the randomized controlled studies conducted by pharmaceutical companies to test the efficacy of their products. Ultimately, the parties reached a settlement agreement of $430 million to resolve all civil claims and criminal charges stemming from the qui tam complaint. At the time of the settlement in May 2004, it represented one of the largest False Claims Act recoveries against a pharmaceutical company in U.S. history, and was the first off-label promotion settlement under the False Claims Act.".
- Q16839058 wikiPageWikiLink Q1141363.
- Q16839058 wikiPageWikiLink Q119697.
- Q16839058 wikiPageWikiLink Q123220.
- Q16839058 wikiPageWikiLink Q131755.
- Q16839058 wikiPageWikiLink Q133823.
- Q16839058 wikiPageWikiLink Q14743875.
- Q16839058 wikiPageWikiLink Q1553390.
- Q16839058 wikiPageWikiLink Q181923.
- Q16839058 wikiPageWikiLink Q204711.
- Q16839058 wikiPageWikiLink Q20539242.
- Q16839058 wikiPageWikiLink Q206921.
- Q16839058 wikiPageWikiLink Q2123051.
- Q16839058 wikiPageWikiLink Q2782326.
- Q16839058 wikiPageWikiLink Q281126.
- Q16839058 wikiPageWikiLink Q284868.
- Q16839058 wikiPageWikiLink Q3064815.
- Q16839058 wikiPageWikiLink Q3067874.
- Q16839058 wikiPageWikiLink Q3543802.
- Q16839058 wikiPageWikiLink Q4046487.
- Q16839058 wikiPageWikiLink Q410352.
- Q16839058 wikiPageWikiLink Q41571.
- Q16839058 wikiPageWikiLink Q4686866.
- Q16839058 wikiPageWikiLink Q5233812.
- Q16839058 wikiPageWikiLink Q5246046.
- Q16839058 wikiPageWikiLink Q651270.
- Q16839058 wikiPageWikiLink Q6625029.
- Q16839058 wikiPageWikiLink Q6631577.
- Q16839058 wikiPageWikiLink Q6806601.
- Q16839058 wikiPageWikiLink Q6996296.
- Q16839058 wikiPageWikiLink Q6998984.
- Q16839058 wikiPageWikiLink Q7148511.
- Q16839058 wikiPageWikiLink Q7445671.
- Q16839058 wikiPageWikiLink Q7889776.
- Q16839058 wikiPageWikiLink Q7969801.
- Q16839058 wikiPageWikiLink Q8760074.
- Q16839058 wikiPageWikiLink Q919364.
- Q16839058 comment "Franklin v. Parke-Davis is a lawsuit filed in 1996 against Parke-Davis, a division of Warner-Lambert Company, and eventually against Pfizer (which bought Warner-Lambert in 2000) under the qui tam provisions of the False Claims Act. The suit was commenced by Dr. David Franklin, a microbiologist hired in the spring of 1996 in a sales capacity at Parke-Davis, a pharmaceutical subsidiary of Warner-Lambert (Warner-Lambert was subsequently acquired by Pfizer in 2000).".
- Q16839058 label "Franklin v. Parke-Davis".